PGD2, IL-1-family members and mast cells

European Journal of Inflammation

Volumn 8, Issue 3, 2010, Pages 137-142

  Anogeianaki, A ^a   Castellani, M L ^b   Tripodi, D ^b   Felaco, P ^b   Toniato, E ^b   De Lutiis, M A ^b   Fulcheri, M ^b   Tete S ^b   Galzio, R ^c   Salini, V ^b   Caraffa, A ^d   Antinolfi, P ^d   Frydas, I ^e   Sabatino, G ^b   Shaik Dasthagirisaheb, Y B ^f   Sharma, Jagdish N ^g  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cytokines; IL 1; Inflammation; Prostaglandins

Indexed keywords

HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 33; LYMPHOCYTE MEMBRANE RECEPTOR; PROSTAGLANDIN D2;

CELL ACTIVATION; CROSS LINKING; DISEASE SEVERITY; HOST RESISTANCE; HUMAN; IMMUNOCYTOTOXICITY; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; REVIEW; TUMOR REJECTION;

EID: 80053519729     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1000800301     Document Type: Review

References (61)

1. Arend WP, Palmer G, Gabay C. IL-1, IL-18 and IL-33 families of cytokines. Immunol Rev 2008; 223:20-38. (Pubitemid 351986169)
2. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med 1998; 188:1135-45. (Pubitemid 28443337)
3. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-65.
4. Cencioni MT, Notturno F, Caporale CM, Creati B, Prencipe V, Battistini L, Uncini A. T cell response in acute motor axonal neuropathy. Int J Immunopathol Pharmacol 2009; 22:1043-50.
5. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM, Moller A. Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell 1998; 9:875-84. (Pubitemid 28173640)
6. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57-79.
7. Cheung PF, Wong CK, Ho AW, Hu S, Chen DP, Lam CW. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol 2010; 22:453-67.
8. Zuccotti GV, Trabattoni D, Morelli M, Borgonovo S, Schneider L, Clerici M. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J Biol Regul Homeost Agents 2009; 23:119-24.
9. Sessa R, Di Pietro M, Schiavoni G, et al. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int J Immunopathol Pharmacol 2009; 22:659-68.
10. Tarantino G, Conca P, Tarantino M, Di Minno MND, Grimaldi E, Chianese D, Riccio A, Scopacasa F, Capone D. Does spleen volume play a role in patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 2009; 22:1009-1017.
11. Saria A. Neuroimmune interactions in the airways: implications for asthma, allergy, and other inflammatory airway diseases. Brain Behav Immun 1988; 2:318-21.
12. Theoharides TC, Konstantinidou A. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007; 12:1615-28.
13. Theoharides TC, Spanos CP, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E, Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 1995; 136:5745-50.
14. Cabrelle A, Maschio N, Carraro S, Frezzato F, Binotto G, Gattazzo C, Miorin M, Agostini C, Zambello R, Pandolfi F, Semenzato G, Trentin L. Apoptotic effect of cyclosporin A and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukaemia. J Biol Regul Homeost Agents 2009; 23:239-250.
15. Burastero SE, Paolucci C, Fabbri M. Ambient pollutants as adjuvant for allergic sensitization: the emerging role of platinum group elements. J Biol Regul Homeost Agents 2009; 23:207-15.
16. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmacol Exp Ther 1999; 288:1349-56. (Pubitemid 29254177)
17. Esposito P, Gheorghe D, Kandere K, Pang X, Conally R, Jacobson S, Theoharides TC. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 2001; 888:117-27. (Pubitemid 32056268)
18. Esposito P, Chandler N, Kandere-Grzybowska K, Basu S, Jacobson S, Connolly R, Tutor D, Theoharides TC. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002; 303:1061-6. (Pubitemid 35424390)
19. Di Paola R, Crisafulli C, Mazzon E, Genovese T, Paterniti I, Bramanti P, Cuzzocrea S. Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. Int J Immunopathol Pharmacol 2009; 22:937-50.
20. Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22:919-27.
21. Amedei A, Della Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D'Elios MM. Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol 2009; 22:979-90.
22. Wilms H, Rosenstiel P, Romero-Ramos M, et al. Suppression of map kinases inhibits microglial activation and attenuates neuronal cell death induced by α-synuclein protofibrils. Int J Immunopathol Pharmacol 2009; 22:897-909.
23. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 1998; 139:403-13. (Pubitemid 28166335)
24. Markert UR, Arck PC, McBey BA, Manuel J, Cray BA, Marshall JS, Chaouat G, Clark DA. Stress triggered abortions are associated with alterations of granulated cells into the decidua. Am J Reprod Immunol 1997; 37:94-100. (Pubitemid 27075973)
25. Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of subcutaneous anti-TNFα treatment in Italian patients. Int J Immunopathol Pharmacol 2009; 22:1147-52.
26. Castellani ML, Conti P, Felaco M, Vecchiet J, Ciampoli C, Cerulli G, Boscolo P, Theoharides TC. Substance P Upregulates LTB(4) in Rat Adherent Macrophages from Granuloma Induced by KMnO(4). Neurotox Res 2009; 15:49-56.
27. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFα and its receptors in psoriatic skin, before and after treatment with Etanercept. Int J Immunopathol Pharmacol 2009; 22:961-6.
28. Kanbe N, Kurosawa M, Nagata H, Saitoh H, Miyachi Y. Cord blood-derived human cultured mast cells produce transforming growth factor beta 1. Clin Exp Allergy 1999; 29:105-13. (Pubitemid 29067659)
29. Di Lorenzo G, Mansueto P, Pacor ML, et al. Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1077-87.
30. Zampetti A, Mastrofrancesco A, Flori E, Maresca V, Picardo M, Amerio P, Feliciani C. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-75.
31. Felaco P, Toniato E, Castellani ML, et al. Infections and mast cells. J Biol Regul Homeost Agents 2009; 23:231-8.
32. Castellani ML, Felaco M, Pandolfi F, et al. IL-32: a newly-discovered proinflammatory cytokine. J Biol Regul Homeost Agents 2009; 23:141-7.
33. Castellani ML, Kempuraj DJ, Salini V, et al. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents 2009; 23:11-14.
34. Rittner HL, Brack A, Stein C. Pain and the immune system. Br J Anaesth 2008; 101:40-4. (Pubitemid 351881900)
35. Riccio A, Morelli G, Sangiolo MG, Morante R, Esposito C, Tarantino G. A lupus hepatitis case and its association with Ig antibodies against cytomegalovirus, herpes simplex and herpes zoster viruses. Eur J Inflamm 2009; 7:45-48.
36. Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med 1998; 188:1135-45. (Pubitemid 28443337)
37. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010; 184:3336-40.
38. Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis. J Biol Regul Homeost Agents 2009; 23:31-36.
39. Theoharides TC, Zhang B, Kempuraj D, Teté, al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci USA 2010; 107:4448-53.
40. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-8.
41. Yip KH, Huang Y, Waye MM, Lau HY. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int Immunopharmacol 2008; 8:764-8.
42. Kovarova M, Latour AM, Chason KD, Tilley SL, Koller BH. Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases. Blood 2010; 115:3695-703.
43. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med. 2008; 358:1860-1. (Pubitemid 351581204)
44. Katayama I, Otoyama K, Yokozeki H, Nishioka K. Effect of mast cell modulators on IgE-mediated murine biphasic cutaneous reactions. Int Arch Allergy Immunol. 1996; 109:390-7. (Pubitemid 26082848)
45. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22:879-88.
46. Li Q, Kobayashi M, Wakayama Y, et al. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22:951-9.
47. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-8.
48. Artuc M, Hermes B, Steckelings UM, Grützkau A, Henz BM. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp Dermatol. 1999; 8:1-16. (Pubitemid 29038037)
49. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-35.
50. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL. Sublingual immunotherapy affects specific antibody and TGF-β serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1089-96.
51. D'Agosto G, Trento E, Nosotti L, et al. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines. J Biol Regul Homeost Agents 2009; 23:155-64.
52. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009; 22:1131-34.
53. Marasini B, Conciato L, Belloli L, Massarotti M. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009; 22:573-8.
54. Santos J, Yang PC, Söderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48:630-6. (Pubitemid 32378581)
55. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 2008; 8:460-71.
56. Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Covoni M. Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 2009; 22:1125-9.
57. Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols. Int J Immunopathol Pharmacol 2009; 22:1001-7.
58. Gobba F, Bargellini A, Bravo G, Scaringi M, Cauteruccio L, Borella P. Natural killer cell activity decreases in workers occupationally exposed to extremely low frequency magnetic fields exceeding 1 μT. Int J Immunopathol Pharmacol 2009; 22:1059-66.
59. Tzeng SF, Hsiao HY, Mak OT. Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr Drug Targets Inflamm Allergy 2005; 4:335-40.
60. Lee H, Han AR, Kim Y, Choi SH, Ko E, Lee NY, Jeong JH, Kim SH, Bae H. A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma. Int J Immunopathol Pharmacol 2009; 22:591-603.
61. Lorentz A, Schwengberg S, Selige G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000; 164:43-8. (Pubitemid 30012970)